CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA Conference

Kawakibi, Abed Rahman, Tarapore, Rohinton, Gardner, Sharon et al. (2022). CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA . NEURO-ONCOLOGY, 24 86-87.

Industry Collaboration International Collaboration

cited authors

  • Kawakibi, Abed Rahman; Tarapore, Rohinton; Gardner, Sharon; Chi, Andrew; Kurz, Sylvia; Wen, Patrick Y; Arrillaga-Romany, Isabel; Batchelor, Tracy; Butowski, Nicholas; Sumrall, Ashley; Shonka, Nicole; Harrison, Rebecca; DeGroot, John; Mehta, Minesh; Odia, Yazmin; Hall, Matthew; Daghistani, Doured; Cloughesy, Timothy; Ellingson, Benjamin; Kim, Michelle; Umemura, Yoshie; Garton, Hugh; Franson, Andrea; Schwartz, Jonathan; Li, Sunjong; Cartaxo, Rodrigo; Ravi, Karthik; Cantor, Evan; Cummings, Jessica; Paul, Alyssa; Walling, Dustin; Dun, Matthew; Cain, Jason; Li, Jiang; Filbin, Mariella; Zhao, Lili; Kumar-Sinha, Chandan; Mody, Rajen; Chinnaiyan, Arul; Kurokawa, Ryo; Pratt, Drew; Venneti, Sriram; Grill, Jacques; Kline, Cassie; Mueller, Sabine; Resnick, Adam C; Nazarian, Javad; Waszak, Sebastian; Allen, Joshua E; Koschmann, Carl

authors

date/time interval

  • November 16, 2022 -

publication date

  • November 1, 2022

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • FL, Tampa

Conference

  • 27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 86

end page

  • 87

volume

  • 24